MEDSNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
DataMeds AI, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 17, 2026
$2.67+0.04 (+1.52%)
Close on Oct 19, 2026
- Market cap
- $6.87M
- P/E (TTM)
- –
- Dividend yield
- –
DataMeds AI statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Wholesale-Drugs, Proprietaries & Druggists' Sundries companies for comparison
Valuation
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Market Cap | $8.18M | $78.64M |
| Enterprise Value | $37.53M | $164.35M |
| PS Ratio | 1.02 | 0.28 |
Enterprise value
| Measure | DataMeds AI | Industry median |
|---|---|---|
| EV / Sales | 4.68 | 0.40 |
Income (trailing twelve months)
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Revenue | $8.02M | $716.39M |
| Gross Profit | -$7.27M | $163.57M |
| Operating Income | -$70.26M | -$30.27K |
| Pretax Income | -$88.28M | $413.10K |
| Net Income | -$88.28M | -$63.82K |
| EBITDA | -$67.94M | $2.60M |
| EPS (Diluted) | -$48.05 | $0.02 |
Margins
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Gross Margin | -90.6% | 14.7% |
| Operating Margin | -875.7% | 0.44% |
| Pretax Margin | -1100.3% | 0.25% |
| Profit Margin | -1100.3% | -0.13% |
| EBITDA Margin | -846.8% | 1.23% |
Returns
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Return on Assets (ROA) | -203.0% | -0.67% |
| Return on Invested Capital (ROIC) | -330.3% | 3.04% |
Growth
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -78.2% | 3.83% |
Balance sheet
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $2.46M | $9.33M |
| Total Debt | $31.81M | $349.35M |
| Net Cash (Debt) | -$29.35M | -$1.85M |
| Net Cash Per Share | -$9.59 | -$0.06 |
| Equity (Book Value) | -$19.50M | $16.46M |
| Book Value Per Share | -$6.37 | $0.34 |
| Tangible Book Value | -$36.64M | $8.19M |
| Working Capital | -$33.78M | $12.53M |
Financial position
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Current Ratio | 0.14 | 1.31 |
| Quick Ratio | 0.09 | 0.55 |
| Interest Coverage | -11.84 | 0.82 |
Cash flow (trailing twelve months)
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Operating Cash Flow | -$13.74M | $3.55M |
Efficiency
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Asset Turnover | 0.18 | 1.65 |
| Inventory Turnover | 2.90 | 9.79 |
| Revenue Per Employee | $229.23K | $1.02M |
| Profits Per Employee | -$2.52M | -$8.95K |
| Employee Count | 35 | 559 |
Dividends and yields
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Earnings Yield | -1079.8% | -0.31% |
Shares
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Shares Outstanding | 3,061,920 | 32,773,350 |
| Shares Change (YoY) | 91.7% | 0.00% |
| Shares Change (QoQ) | 18.8% | 0.00% |
| Shares Held by Institutions | 1.69% | 76.1% |
Scores
| Measure | DataMeds AI | Industry median |
|---|---|---|
| Altman Z-Score | -13.84 | 3.72 |
| Piotroski F-Score | 1 | 4 |
Calculated by StockData from DataMeds AI's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.